Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans

Neuroscience

Volumn 65, Issue 1, 1995, Pages 87-91

  McRitchie, D A ^a   Halliday, G M ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; SUBSTANCE P; CALCIUM BINDING PROTEIN; CALCIUM BINDING PROTEINS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; AUTOPSY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MESENCEPHALON; NERVE CELL; PHYSIOLOGY;

ADULT; AGED; AUTOPSY; CALCIUM-BINDING PROTEINS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; MIDDLE AGE; NEURONS; SUBSTANCE P; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T;

EID: 0028983148     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(94)00483-L     Document Type: Article

References (59)

1. Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia
2. Depletion in substance P- and neurokinin A-like immunoreactivity in substantia nigra after ibotenate-induced lesions of striatum
3. Calcium-binding proteins in the nervous system
4. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
5. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
6. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat
7. Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult
8. Calbindin D-28k and parvalbumin in the rat nervous system
9. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies
10. Topographical localization of substance P in the human post mortem brainstem. An immunohistochemical study in the newborn and adult tissue
11. Ageing and Parkinson's disease: Substantia nigra regional selectivity
12. Selective localization of calcium-binding protein in human brainstem, cerebellum and spinal cord
13. Rapid, reliable and economical silver stain for neurofibrillary tangles and senile plaques
14. Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon
15. The neostriatal mosaic: Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey
16. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems
17. The neostriatal mosiac: II. Patch- and matrix directed mesostriatal dopaminergic and non-dopaminergic systems
18. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization
19. 28k-containing cells
20. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease
21. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease
22. The brain-stem lesions in parkinsonism
23. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra
24. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
25. Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human
26. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
27. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
28. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease
29. Neocortical subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease
30. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures
31. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases
32. Ontogeny of substance P-containing neuron system of the rat: immunohistochemical analysis—I. Forebrain and upper brain stem
33. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease
34. Overview of the morphological changes in Parkinson's disease
35. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis
36. Immunohistochemistry of tyrosine hydroxylase and phenylethanolamine N-methyltransferase in the human brain stem: description of adrenergic perikarya and characterization of longitudinal catecholaminergic pathways
37. 28k as a marker for the degeneration of the striatonigral pathway in Huntington's disease
38. Two distinct strio-nigral substance P pathways in the rat: an experimental immunohistochemical study
39. Distribution of substance P-like immunoreactivity in the central nervous system
40. Substance P in the human brain
41. 28k in cultured hippocampal neurons
42. 2+-binding protein parvalbumin
43. Distribution of substance P-like immunoreactive structures in the brainstem of the adult human brain: an immunohistochemical study
44. A quantitative investigation of the substantia nigra in Huntington's disease
45. Ultrastructural localization of brain “vitamin D-dependent” calcium binding proteins
46. Catecholaminergic neurons
47. The EF-hand family of calcium modulating proteins
48. Distribution of substance P- and enkephalin-immunoreactive neurons and fibres
49. Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease
50. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation
51. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system
52. 28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity
53. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus
54. Selective loss of nigral neurons in Alzheimer's disease: a morphometric study
55. Selective loss of nigral neurons in Pick's disease: a morphometric study
56. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea
57. Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro
58. 28k